Addus HomeCare’s (ADUS) “Outperform” Rating Reiterated at Royal Bank of Canada

Royal Bank of Canada reissued their outperform rating on shares of Addus HomeCare (NASDAQ:ADUS) in a research note released on Thursday morning,Benzinga reports. Royal Bank of Canada currently has a $136.00 price objective on the stock.

ADUS has been the topic of a number of other reports. KeyCorp started coverage on Addus HomeCare in a research note on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target on the stock. Stephens raised their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. Oppenheimer increased their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. TD Cowen lifted their price target on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a report on Thursday, August 8th. Finally, Macquarie restated an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Addus HomeCare currently has an average rating of “Moderate Buy” and an average price target of $131.63.

Addus HomeCare Trading Down 1.6 %

NASDAQ:ADUS traded down $1.92 during trading hours on Thursday, reaching $120.15. 41,577 shares of the company were exchanged, compared to its average volume of 131,245. The firm has a market cap of $2.18 billion, a PE ratio of 27.93, a price-to-earnings-growth ratio of 2.15 and a beta of 1.04. Addus HomeCare has a twelve month low of $85.43 and a twelve month high of $136.12. The stock’s 50-day moving average is $129.12 and its 200-day moving average is $122.06.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. During the same period in the previous year, the company earned $1.03 EPS. The company’s revenue for the quarter was up 7.1% on a year-over-year basis. As a group, research analysts anticipate that Addus HomeCare will post 4.58 EPS for the current year.

Insiders Place Their Bets

In other news, Director Esteban Lopez sold 500 shares of the stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total transaction of $65,015.00. Following the completion of the sale, the director now owns 3,866 shares of the company’s stock, valued at approximately $502,695.98. This represents a 11.45 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. This trade represents a 75.23 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 22,917 shares of company stock worth $3,050,082. Corporate insiders own 4.60% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

Institutional investors and hedge funds have recently made changes to their positions in the company. UMB Bank n.a. grew its holdings in Addus HomeCare by 64.2% during the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after buying an additional 88 shares in the last quarter. Quarry LP bought a new position in shares of Addus HomeCare during the third quarter valued at approximately $28,000. Quest Partners LLC purchased a new position in Addus HomeCare in the second quarter valued at about $31,000. EntryPoint Capital LLC purchased a new position in Addus HomeCare in the first quarter worth $44,000. Finally, Innealta Capital LLC purchased a new position in shares of Addus HomeCare in the 2nd quarter valued at approximately $44,000. Institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.